<DOC>
	<DOC>NCT01013454</DOC>
	<brief_summary>This study will evaluate the single-dose pharmacokinetics, safety, and tolerability of a varenicline patch applied to the skin.</brief_summary>
	<brief_title>A Study Evaluating The Absorption Of Varenicline Into The Body From A Varenicline Patch Applied To The Skin</brief_title>
	<detailed_description />
	<mesh_term>Varenicline</mesh_term>
	<criteria>Healthy, Caucasian, male, adult light to regular smokers Evidence or history of clinically significant hematological, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric, neurologic, or allergic disease (including drug allergies, but excluding untreated, asymptomatic, seasonal allergies at time of dosing). Any condition possibly affecting drug absorption through the skin (eg, psoriasis).</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>varenicline percutaneous transcutaneous topical transdermal transdermal delivery system patch</keyword>
</DOC>